語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Bone regulators and osteoporosis therapy
~
SpringerLink (Online service)
Bone regulators and osteoporosis therapy
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Bone regulators and osteoporosis therapyedited by Paula H. Stern.
其他作者:
Stern, Paula H.
出版者:
Cham :Springer International Publishing :2020.
面頁冊數:
x, 518 p. :ill., digital ;24 cm.
Contained By:
Springer Nature eBook
標題:
OsteoporosisTreatment.
電子資源:
https://doi.org/10.1007/978-3-030-57378-2
ISBN:
9783030573782$q(electronic bk.)
Bone regulators and osteoporosis therapy
Bone regulators and osteoporosis therapy
[electronic resource] /edited by Paula H. Stern. - Cham :Springer International Publishing :2020. - x, 518 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2620171-2004 ;. - Handbook of experimental pharmacology ;208..
The cells of bone their interactions -- Parathyroid hormone and bone -- Vitamin D and bone -- Gonadal hormones and bone -- Thyroid hormones, glucocorticoids, insulin, and bone -- Growth factors and bone -- Prostaglandins and bone -- Cytokines and bone: osteoimmunology -- Chemokines and bone -- Calcium and bone -- FGF-23 and bone and mineral metabolism -- Nervous system mediators and bone -- Genetics of bone disorders -- Osteoporosis pathogenesis -- Structural and metabolic assessment of bone status -- Osteoporosis Therapeutics 2019 -- New targets and emergent therapies for osteoporosis -- Drugs causing bone loss -- Natural Products as potential bone therapies.
This volume is designed to provide an understanding of current and potential therapies for osteoporosis. The opening chapter introduces the cells of bone and their interactions. Several following chapters describe factors affecting bone including systemic hormones with significant effects on bone, and local mediators including growth factors, prostaglandins, cytokines and chemokines. Topics that have commanded particular attention recently are calcium, FGF-23, nervous system bone interactions. Drugs that cause bone loss provide important information on mechanism as well as therapeutic considerations. An overview of the genetics of bone disorders and a discussion of the pathophysiology of osteoporosis establish the clinical context. The final chapters discuss current and potential osteoporosis treatments.
ISBN: 9783030573782$q(electronic bk.)
Standard No.: 10.1007/978-3-030-57378-2doiSubjects--Topical Terms:
318005
Osteoporosis
--Treatment.
LC Class. No.: RC931.O73
Dewey Class. No.: 616.716
Bone regulators and osteoporosis therapy
LDR
:02527nmm a2200337 a 4500
001
589285
003
DE-He213
005
20210224163110.0
006
m d
007
cr nn 008maaau
008
210601s2020 sz s 0 eng d
020
$a
9783030573782$q(electronic bk.)
020
$a
9783030573775$q(paper)
024
7
$a
10.1007/978-3-030-57378-2
$2
doi
035
$a
978-3-030-57378-2
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC931.O73
072
7
$a
MMG
$2
bicssc
072
7
$a
MED071000
$2
bisacsh
072
7
$a
MKG
$2
thema
082
0 4
$a
616.716
$2
23
090
$a
RC931.O73
$b
B712 2020
245
0 0
$a
Bone regulators and osteoporosis therapy
$h
[electronic resource] /
$c
edited by Paula H. Stern.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2020.
300
$a
x, 518 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Handbook of experimental pharmacology,
$x
0171-2004 ;
$v
v.262
505
0
$a
The cells of bone their interactions -- Parathyroid hormone and bone -- Vitamin D and bone -- Gonadal hormones and bone -- Thyroid hormones, glucocorticoids, insulin, and bone -- Growth factors and bone -- Prostaglandins and bone -- Cytokines and bone: osteoimmunology -- Chemokines and bone -- Calcium and bone -- FGF-23 and bone and mineral metabolism -- Nervous system mediators and bone -- Genetics of bone disorders -- Osteoporosis pathogenesis -- Structural and metabolic assessment of bone status -- Osteoporosis Therapeutics 2019 -- New targets and emergent therapies for osteoporosis -- Drugs causing bone loss -- Natural Products as potential bone therapies.
520
$a
This volume is designed to provide an understanding of current and potential therapies for osteoporosis. The opening chapter introduces the cells of bone and their interactions. Several following chapters describe factors affecting bone including systemic hormones with significant effects on bone, and local mediators including growth factors, prostaglandins, cytokines and chemokines. Topics that have commanded particular attention recently are calcium, FGF-23, nervous system bone interactions. Drugs that cause bone loss provide important information on mechanism as well as therapeutic considerations. An overview of the genetics of bone disorders and a discussion of the pathophysiology of osteoporosis establish the clinical context. The final chapters discuss current and potential osteoporosis treatments.
650
0
$a
Osteoporosis
$x
Treatment.
$3
318005
650
0
$a
Osteoporosis
$x
Pathophysiology.
$3
379851
650
0
$a
Bones
$x
Pathophysiology.
$3
384701
650
0
$a
Pharmacology.
$3
218135
650
0
$a
Cell physiology.
$3
194355
650
0
$a
Cytokines.
$3
195178
650
0
$a
Growth factors.
$3
250597
650
0
$a
Metabolism
$x
Disorders.
$3
318679
650
0
$a
Proteins.
$3
193852
650
0
$a
Endocrinology.
$3
196517
650
1 4
$a
Pharmacology/Toxicology.
$3
273652
650
2 4
$a
Cell Physiology.
$3
238835
650
2 4
$a
Cytokines and Growth Factors.
$3
379480
650
2 4
$a
Metabolic Diseases.
$3
274217
650
2 4
$a
Receptors.
$3
337756
700
1
$a
Stern, Paula H.
$3
881120
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer Nature eBook
830
0
$a
Handbook of experimental pharmacology ;
$v
208.
$3
559421
856
4 0
$u
https://doi.org/10.1007/978-3-030-57378-2
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000191720
電子館藏
1圖書
電子書
EB RC931.O73 B712 2020 2020
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
https://doi.org/10.1007/978-3-030-57378-2
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入